Since 1987, this conference has fostered a highly interactive community of researchers focused on solving important problems in immunoreceptor and immunotherapy biology. It brings together scientists from academia, government, and industry to discuss cutting-edge developments in this exciting area of research.
The conference has a history of driving major advances in immunotherapies by bringing together leading scientists, clinicians, and industry experts to share the latest discoveries and technological advances.
This year’s program will continue that tradition of innovation by examining the structural and functional dynamics of immunoreceptors, their mechanisms of activation and regulation, and translational research driving new immunotherapeutic strategies. As key molecules that regulate immune responses, research into immunoreceptors has yielded precise and effective therapies, including checkpoint inhibitors, CAR-T cell therapies, and novel monoclonal antibodies.